Linagliptin as add-on treatment to glimepiride in patients with HNF1A-diabetes (MODY3): a randomised, double-blinded, placebo-controlled, crossover trial A. S. Christensen,S. Haedersdal, J. Stoy,H. Storgaard, U. Kampmann, M. Seghieri,J. J. Holst,T. Hansen,F. K. Knop, T. VilsbollDIABETOLOGIA（2020）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
